119 related articles for article (PubMed ID: 7131282)
1. Anthralin: chemical instability and glucose-6-phosphate dehydrogenase inhibition.
Cavey D; Caron JC; Shroot B
J Pharm Sci; 1982 Sep; 71(9):980-3. PubMed ID: 7131282
[TBL] [Abstract][Full Text] [Related]
2. Anthralin: chemical instability and glucose-6-phosphate dehydrogenase inhibition.
Cavey D; Caron JC; Shroot B
Br J Dermatol; 1981 Aug; 105 Suppl 20():15-9. PubMed ID: 7284258
[No Abstract] [Full Text] [Related]
3. Dithranol (anthralin) versus triacetoxyanthracene. Investigations in vitro.
Raab W
Br J Dermatol; 1976 Aug; 95(2):193-6. PubMed ID: 782506
[TBL] [Abstract][Full Text] [Related]
4. [Senecioyldithranol and beta-carbethoxypropionyldithranol: synthesis and glucose-6-phosphate dehydrogenase inhibition of two new 10-acyl derivatives of the antipsoriatic, dithranol].
Rychener M; Steiger W; Krebs A
Pharm Acta Helv; 1988; 63(4-5):111-6. PubMed ID: 3222264
[No Abstract] [Full Text] [Related]
5. Antipsoriatic drug action of anthralin: oxidation reactions with peroxidizing lipids.
Ducret F; Lambelet P; Löliger J; Savoy MC
J Free Radic Biol Med; 1985; 1(4):301-6. PubMed ID: 3836247
[TBL] [Abstract][Full Text] [Related]
6. Influence of ultraviolet light, various temperatures, and zinc ions on anthralin (dithranol). Biochemical and chemical investigations.
Raab WP; Gmeiner BM
Dermatologica; 1975; 150(5):267-76. PubMed ID: 1183690
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantitation of 1,8,9-anthracenetriol, 1,8-dihydroxy-9,10-anthraquinone, and 1,8,1',8'-tetrahydroxy-10,10'-dianthrone by reversed-phase high-performance liquid chromatography.
Wurster DE; Upadrashta SM
J Chromatogr; 1986 Jul; 362(1):71-8. PubMed ID: 3745364
[TBL] [Abstract][Full Text] [Related]
8. [Synthesis and biochemical properties of new 10-acyl derivatives of dithranols: acetylsalicyldithranol and 1-acetyllactyldithranol].
Berset JD; Krebs A
Pharm Acta Helv; 1990; 65(1):14-9. PubMed ID: 2330383
[TBL] [Abstract][Full Text] [Related]
9. [Glucose-6-phosphate dehydrogenase and topical antipsoriatics. A comparison of anthralin, anthralin-monoacetate, anthralin-diacetate, anthralin-triacetate and 6-hydroxy-2-oxobenzoxathiole (author's transl)].
Raab W; Siber H
Arch Dermatol Forsch; 1974; 249(2):179-89. PubMed ID: 4418435
[No Abstract] [Full Text] [Related]
10. [10-Acyldithranol dimers; new derivatives of the antipsoriatic dithranol; synthesis, characterization and biochemical properties].
Berset JD; Krebs A
Pharm Acta Helv; 1990; 65(5-6):155-64. PubMed ID: 2371307
[TBL] [Abstract][Full Text] [Related]
11. [Fumaryldithranol and sorbyldithranol: synthesis and glucose-6-phosphate-dehydrogenase antagonism in extended 10-acylation products in the antipsoriatic dithranol. 2].
Rychener M; Steiger W; Krebs A
Pharm Acta Helv; 1988; 63(12):322-6. PubMed ID: 3241812
[No Abstract] [Full Text] [Related]
12. Anthralin and its acetyl esters: spectroscopic properties and enzyme inhibitory activity.
Wiegrebe W; Retzow A; Plumier E
Br J Dermatol; 1981 Aug; 105 Suppl 20():12-4. PubMed ID: 7284257
[No Abstract] [Full Text] [Related]
13. Ingram method: the precursor of photochemotherapy.
Raab WP
Br J Dermatol; 1981 Aug; 105 Suppl 20():77-81. PubMed ID: 7284273
[No Abstract] [Full Text] [Related]
14. [Antipsoriatic effect of dithranol (anthralin). 1].
Raab W
Hautarzt; 1975 Sep; 26(9):452-5. PubMed ID: 1184389
[TBL] [Abstract][Full Text] [Related]
15. [Study on the mode of action of dithranol: increased lipid peroxidation and enzyme inhibition].
Diezel W; Meffert H; Sönnichsen N
Dermatologica; 1975; 150(3):154-62. PubMed ID: 125665
[TBL] [Abstract][Full Text] [Related]
16. On the interaction between anthralin and DNA: a revision.
Caron JC; Eustache J; Shroot B; Prota G
Arch Dermatol Res; 1982; 274(3-4):207-12. PubMed ID: 7165372
[TBL] [Abstract][Full Text] [Related]
17. A microspectrofluorometric study of the effect of anthralin, an antipsoriatic drug, on cellular structures and metabolism.
Kohen E; Kohen C; Morliere P; Santus R; Reyftmann JP; Dubertret L; Hirschberg JG; Coulomb B
Cell Biochem Funct; 1986 Jul; 4(3):157-68. PubMed ID: 3731395
[TBL] [Abstract][Full Text] [Related]
18. [Purification, glucose-6-phosphate dehydrogenase inhibition, and HPLC analysis of four 1,8-dihydroxyanthrones].
Rychener M; Steiger W
Pharm Acta Helv; 1989; 64(1):8-15. PubMed ID: 2717648
[TBL] [Abstract][Full Text] [Related]
19. Structure and tumor-promoting activity of analogues of anthralin (1,8-dihydroxy-9-anthrone).
Van Duuren BL; Segal A; Tseng SS; Rusch GM; Loewengart G; Maté U; Roth D; Smith A; Melchionne S; Seidman I
J Med Chem; 1978 Jan; 21(1):26-31. PubMed ID: 619147
[TBL] [Abstract][Full Text] [Related]
20. High-pressure liquid chromatographic determination of anthralin in ointments.
Caron JC; Shroot B
J Pharm Sci; 1981 Nov; 70(11):1205-7. PubMed ID: 7299664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
